\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ is\\ non\\-contributory\ \(0\)\
\-\ a\\ lumbar\\ puncture\\ was\\ performed\\ and\\ csf\\ analysis\\ is\\ positive\ \(0\)\
\-\ antiviral\\ chemotherapy\ \(0\)\
\-\ \\â\\€\\¢\\ subtle\\ increase\\ in\\ t2\\ signal\\ within\\ the\\ midbrain\\ surrounding\\ the\\ red\\ nuclei\\ and\\ involving\\ the\\ substantia\\ nigra\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ mass\\ effect\\ nor\\ pathologic\\ enhancement\\.\ \(0\)\
\-\ west\\ nile\\ encephalitis\ \(0\)\
\-\ \\â\\€\\¢\\ demyelinating\\ disease\ \(0\)\
\-\ \\Â\\»\\ adem\ \(0\)\
\-\ \\Â\\»\\ multiple\\ sclerosis\ \(0\)\
\-\ \\â\\€\\¢\\ ischemia\\ or\\ infarction\ \(0\)\
\-\ \\â\\€\\¢\\ encephalitis\ \(1\)\
\-\ 56\\ year\\ old\\ man\\ presents\\ to\\ the\\ er\\ with\\ complaints\\ of\\ abdominal\\ pain\\ and\\ mild\\ headache\\.\\ \\ also\\ has\\ recent\\ onset\\ of\\ trouble\\ concentrating\\.\ \(0\)\
\-\ cdc\\ on\\ west\\ nile\\ \\-\\ http\\:\\/\\/www\\.cdc\\.gov\\/ncidod\\/dvbid\\/westnile\\/clinicians\\/clindesc\\.htm\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cdc\\:\\ 0\\.3131114016100849\ \(0\)\
\-\ nile\\:\\ 0\\.3077986323307377\ \(0\)\
\-\ west\\:\\ 0\\.2855333843770891\ \(0\)\
\-\ encephalitis\\:\\ 0\\.22569115529300457\ \(0\)\
\-\ substantia\\:\\ 0\\.18147733339836464\ \(0\)\
\-\ nigra\\:\\ 0\\.18147733339836464\ \(0\)\
\-\ antiviral\\:\\ 0\\.16324925550757216\ \(0\)\
\-\ concentrating\\:\\ 0\\.15655570080504244\ \(0\)\
\-\ trouble\\:\\ 0\\.13669163292973044\ \(0\)\
\-\ midbrain\\:\\ 0\\.12632129893237304\ \(0\)\
\-\ nuclei\\:\\ 0\\.12511527306074874\ \(0\)\
\-\ demyelinating\\:\\ 0\\.12453861429775206\ \(0\)\
\-\ puncture\\:\\ 0\\.1239782016233266\ \(0\)\
\-\ adem\\:\\ 0\\.12188222965807845\ \(0\)\
\-\ nor\\:\\ 0\\.11046742599472935\ \(0\)\
\-\ red\\:\\ 0\\.10688719516995623\ \(0\)\
\-\ 56\\:\\ 0\\.10597239793712337\ \(0\)\
\-\ analysis\\:\\ 0\\.10553030564676387\ \(0\)\
\-\ ischemia\\:\\ 0\\.09828241164318811\ \(0\)\
\-\ subtle\\:\\ 0\\.09783197728269766\ \(0\)\
\-\ pe\\:\\ 0\\.09381299402685239\ \(0\)\
\-\ complaints\\:\\ 0\\.09345237990426532\ \(0\)\
\-\ pathologic\\:\\ 0\\.09298150977119028\ \(0\)\
\-\ lumbar\\:\\ 0\\.09163229218575202\ \(0\)\
\-\ increase\\:\\ 0\\.09109605124498063\ \(0\)\
\-\ the\\:\\ 0\\.09057254373755716\ \(0\)\
\-\ csf\\:\\ 0\\.08966719789223489\ \(0\)\
\-\ infarction\\:\\ 0\\.08908491239059235\ \(0\)\
\-\ er\\:\\ 0\\.08487671612558105\ \(0\)\
\-\ http\\:\\ 0\\.083895062153264\ \(0\)\
\-\ sclerosis\\:\\ 0\\.0808284911392119\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.08057746781669045\ \(0\)\
\-\ effect\\:\\ 0\\.07960389939190515\ \(0\)\
\-\ involving\\:\\ 0\\.07948548633781843\ \(0\)\
\-\ headache\\:\\ 0\\.07822744265302067\ \(0\)\
\-\ recent\\:\\ 0\\.0768364819001771\ \(0\)\
\-\ surrounding\\:\\ 0\\.07568219424848285\ \(0\)\
\-\ positive\\:\\ 0\\.074776712555202\ \(0\)\
\-\ onset\\:\\ 0\\.07286797335418814\ \(0\)\
\-\ and\\:\\ 0\\.07034702488547073\ \(0\)\
\-\ performed\\:\\ 0\\.0671344389528854\ \(0\)\
\-\ enhancement\\:\\ 0\\.06531643185504073\ \(0\)\
\-\ t2\\:\\ 0\\.06528749609088486\ \(0\)\
\-\ signal\\:\\ 0\\.06432791522810045\ \(0\)\
\-\ mild\\:\\ 0\\.06432791522810045\ \(0\)\
\-\ is\\:\\ 0\\.06215389022986614\ \(0\)\
\-\ abdominal\\:\\ 0\\.06206457541881127\ \(0\)\
\-\ man\\:\\ 0\\.060077094886491426\ \(0\)\
\-\ multiple\\:\\ 0\\.055504959334451216\ \(0\)\
\-\ presents\\:\\ 0\\.05458916870148582\ \(0\)\
\-\ also\\:\\ 0\\.053377183470582894\ \(0\)\
\-\ within\\:\\ 0\\.05226484400339157\ \(0\)\
\-\ has\\:\\ 0\\.05183381728300314\ \(0\)\
\-\ disease\\:\\ 0\\.04763437616931637\ \(0\)\
\-\ of\\:\\ 0\\.04441460455956334\ \(0\)\
\-\ mass\\:\\ 0\\.04334587889566129\ \(0\)\
\-\ pain\\:\\ 0\\.040606897027473436\ \(0\)\
\-\ was\\:\\ 0\\.03954849134930429\ \(0\)\
\-\ or\\:\\ 0\\.03947725991885264\ \(0\)\
\-\ no\\:\\ 0\\.03690202016692948\ \(0\)\
\-\ year\\:\\ 0\\.034971937308980114\ \(0\)\
\-\ on\\:\\ 0\\.034272550680945646\ \(0\)\
\-\ old\\:\\ 0\\.033585165653145815\ \(0\)\
\-\ to\\:\\ 0\\.02836948143805927\ \(0\)\
\-\ in\\:\\ 0\\.02822984690917636\ \(0\)\
\-\ with\\:\\ 0\\.022220571137602136\ \(0\)\
